Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2016 15:05 ET | Source: 21st North Inc.

21st North Inc. (formerly known as Urologix, Inc.) Announces Expected Timeline for Administrative Dissolution of the Company

MINNEAPOLIS, April 25, 2016 (GLOBE NEWSWIRE) -- 21st North Inc. announced today that its reconvened Special Meeting of Shareholders commenced earlier today again failed to achieve a quorum. ...
March 29, 2016 17:12 ET | Source: 21st North Inc.

21st North Inc. Announces Special Meeting of Shareholders to Approve the Plan of Dissolution to be Reconvened April 25, 2016

MINNEAPOLIS, March 29, 2016 (GLOBE NEWSWIRE) -- 21st North Inc. (formerly known as Urologix, Inc.) announced today that its Special Meeting of Shareholders commenced earlier today was adjourned...
February 02, 2016 16:05 ET | Source: 21st North Inc.

Urologix Announces Sale of Operating Assets to Private Company Buyer

MINNEAPOLIS, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Urologix, Inc. (OTC Pink:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, announced today...
July 09, 2015 16:00 ET | Source: 21st North Inc.

Urologix Announces SEC Deregistration

MINNEAPOLIS, July 09, 2015 (GLOBE NEWSWIRE) -- Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced...
May 21, 2015 16:00 ET | Source: 21st North Inc.

Costs for In-Office BPH Therapies Presented at the AUA 2015 Annual Meeting in New Orleans

MINNEAPOLIS, May 21, 2015 (GLOBE NEWSWIRE) -- Urologix, Inc. (OTCQB:ULGX), a market leader for the in-office treatment of benign prostatic hyperplasia (BPH) today announced that data...
May 12, 2015 16:01 ET | Source: 21st North Inc.

Urologix Products Featured in Cost-Effectiveness Research to be Presented at Upcoming Industry Meeting in New Orleans

MINNEAPOLIS, May 12, 2015 (GLOBE NEWSWIRE) -- Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced an...
May 12, 2015 16:00 ET | Source: 21st North Inc.

Urologix Reports Third Quarter Fiscal Year 2015 Results

Recent Quarter Results Revenue $2.8 MillionEnding cash balances, including restricted cash of $532,000$2.8 million owed under the Prostiva license and Medtronic promissory note remains past...
March 23, 2015 09:00 ET | Source: 21st North Inc.

Urologix Announces Hiring of Chief Financial Officer

MINNEAPOLIS, March 23, 2015 (GLOBE NEWSWIRE) -- Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced the...
February 05, 2015 16:00 ET | Source: 21st North Inc.

Urologix Reports Second Quarter Fiscal Year 2015 Results

Recent Quarter Highlights Revenue $3.1 Million, 2% increase from first quarter fiscal year 2015. Net loss reduced by 67% to $357,000 from a net loss of $1.1 million in the second quarter of...
January 12, 2015 08:00 ET | Source: 21st North Inc.

Urologix Reports Preliminary Fiscal Year 2015 Second Quarter Revenue and Cash Results

Second quarter preliminary revenue of $3.1M, up 2% sequentially MINNEAPOLIS, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Urologix®, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for...